SORT BY Relevancy
Web Sites, Mobile Apps, Wearables Can Be Hacked!
Pharmaguy interviews Jeff Greene, digital strategy lead at New Solutions Factory. Jeff discusses the the impact on pharma marketing to physicians and consumers of the recent Ashley Madison hack and gives some advice on how to mitigate the risks.
Are we an over medicated society? Will Marijuana always be demonized by the mainstream media? Is it insane that we now live in a country where the FDA has just approved Oxycontin for children, but still considers Cannabis a Schedule 1 Narcotic- what are they high? This week we talk Big Pharma and Legalization. Phone lines will be open so you never know who may be calling in.
Also this week we premier our brand new comedy after show Kettle Of Fish, with special guest comedian Wendi Starling.
So join Dee, Saucey and Badger for all the Verbal Anti-Psychotics we can Prescribe for your Chemically Imbalanced EarHoles!
Not enough? Need More?
LIKE US on Facebook
FOLLOW US on Twitter
Pharmaguy interviews R.J. Lewis, President and CEO of eHealthcare Solutions, about his new book "RESULTS: The Future of Pharmaceutical and Healthcare Marketing," which he co-authored with Scott Weintraub, Brad Sitler, Joanne McHugh, Roger Zan, and Stephen Morales.
The book covers 5 key themes:
Evolving Systems of Care & the ACA
A view from the manufacturers perspective
RJ will focus on the chapter about digital marketing. Questions and topics we will touch on include:
What are some of the biggest trends you are seeing in digital marketing today?
There is a shift from targeting contextually to targeting based on an audience, how is this playing out in digital marketing and where is it heading?
What are some examples of “data driven” targeting in online advertising?
What does the future hold for the newer media and platforms such as mobile and video?
How big of a role does societies concerns over privacy play in how the future unfolds?
For the chapter on a view from the manufacturer, I understand you interviewed over two dozen pharmaceutical executives. What are the main themes you heard from them?
Sanofi's Mission T1D for Children with Type 1 Diabetes
Pharmaguy interviews Becky Reeve, Head of Professional Relations, Diabetes Franchise Sanofi UK & Ireland. We talk about Mission T1D, a new gaming app for children with type 1 diabetes in the UK. Mission T1D aims to support a serious message through gaming and play to encourage children with T1D (and their family, teachers and friends) to learn more about how to live with diabetes.
Questions/Topics of Discussion
Please tell us more about Mission T1D; specifically describe the game, how it is meant to be played, by whom and in what settings.
Is Mission T1D an example of what is often called "gamification?" In general, what role do you see for "gamification" in pharma promotion and patient support?
Obviously, this is an educational game. How do you incorporate education into the game. How do you ensure that kids will not abandon the game if it is "too educational" and not fun?
This is not the first diabetes mobile app created by Sanofi Diabetes for kids in the UK. What is the value proposition for Sanofi to develop these apps?
Are there plans to introduce this game to the U.S. market?
Today Nick & Dr. Joanna will be continuing the discussion on "Pharma to Dharma: From Pharmaceuticals Back to Nature" as it applies to the use of Hypnotherapy in place of, or to minimize the use of pharmaceuticals. The Wetsern model of quick fix medicine is just not working, for doctors and patients alike. Patients are finally realizing that the "quick fix" really isn't giving them the desired result or cure that they are looking for, and doctors are starting to feel that this is not the way to truly practice medicine so that healing on all levels can be invited to occur. Learn how hypnotherapy can be a very viable and safe approach to changing our consciousness to break thinking patterns that do not serve us.
Adverse Drug reactions are the 4th leading cause of death and pharmaceutical companies still continue to rake in billions by marketing and selling disease. How do they do that? By creating new diagnoses that fit into the effects of the drug that is already on the market, but that is usually close to patent expiration. This occurs particularly with psychotropics - drugs for anxiety, insomnia, depression and a variety of other psychiatric illnesses. Many people do not realize that sometimes the side effects of these drugs are exactly that which they are designed to treat. Find out how hypnotherapy can be used alone or to augment any other modality of healing in what promises to be a very interesting discussion.
Pharma to Dharma 4-hour Workshops on 17th & 21st May 2015 and will be offered regularly. See more on the Kalyana Centre homepage. Find us always at www.thekalyanacentre.com or Dr. Joanna at www.drjoannacarmichael.com or 484-412-8815.
Receive 20% off an initial consultation with Nick or Joanna when you mention this show.
Pharmaguy interviews Duncan Lennox is CEO and Co-founder of Qstream, a mobile sales performance platform for igniting high-performing teams, about the use of gaming and mobile technologies to increase the effectiveness of pharma sales teams.
Questions & Topics Covered:
Why is game mechanics playing a larger role in pharma companies’ mobile-first sales strategy? What industry factors are behind this change(s)?
What is the difference between game mechanics and gamification? Why is that important to know?
Studies show that reps – even those with extensive market and product training – will forget up to 79% of new information within days and months. Can you explain this “forgetting curve?” How does game mechanics solve this challenge?
We’ve been talking about how game mechanics-based sales performance methodologies can help sales reps – what about their managers? What kinds of data do sales managers have access to?
Explain how game mechanics might help a typical pharma salesforce?
Today Nick & Dr. Joanna will be talking about her initiative called, "Pharma to Dharma: From Pharmaceuticals Back to Nature." The Wetsern model of quick fix medicine is just not working, for doctors and patients alike. Patients are finally realizing that the "quick fix" really isn't giving them the desired result or cure that they are looking for, and doctors are starting to feel that this is not the way to truly practice medicine so that healing on all levels can be invited to occur.
Adverse Drug reactions are the 4th leading cause of death and pharmaceutical companies still continue to rake in billions by marketing and selling disease. How do they do that? By creating new diagnoses that fit into the effects of the drug that is already on the market, but that is usually close to patent expiration. This occurs particularly with psychotropics - drugs for anxiety, insomnia, depression and a variety of other psychiatric illnesses. Many people do not realize that sometimes the side effects of these drugs are exactly that which they are designed to treat.
How does the food industry fit in to all of this? And it's supposedly monitored by the FDA. But there's a reason it's called the F D A.
So what can we do as healthcare practitioners and consumers of medical care to combat the collusion amongst big pharma, medicine, the mainstream media, and the food industry to keep us fat, sick and dying? Find out in what promises to be a very interesting discussion.
Pharma to Dharma 4-hour Workshops on 17th & 21st May 2015 and will be offered regularly. See more on the Kalyana Centre homepage.
Find us always at www.thekalyanacentre.com or Dr. Joanna at www.drjoannacarmichael.com or 484-412-8815.
Receive 20% off an initial consultation with Nick or Joanna when you mention this show.
Long before the tech sector christened almost every type of analytics as big data, the pharmaceutical and biotech industries were heavily reliant on analytics to develop new, safer drugs, and to produce those drugs more efficiently. Big data plays a key role in building upon what we have learned about the human genome, in managing effective clinical trials, in long-term monitoring of drug applicability in real-world healthcare, and in managing the manufacturing process.
Consider what the use of big data in pharma and biotech companies means to you as a consumer. It means getting the right drug to the right patient at the right time for the right condition. Now, consider what you can learn as a business person -- no matter what industry you are in -- from the analytics techniques, and the data management and data mining concepts pioneered by big pharma.
Jim Baxter, head of the life sciences practice at Collaborative Consulting, joins All Analytics Radio on Tuesday, May 19, at 2 pm EDT, for a discussion of how pharma and biotech companies finding benefits in big data analytics.
In this show you will learn:
How use of big data analytics have evolved in the drug and medical device industries
What types of benefits life sciences companies are finding through use of analytics
What big data in pharma means to you as a possible patient
What the future holds for use of analytics in life sciences
What lessons big pharma can teach analytics professionals and decision makers about use of big data in their own business environments
The Mobile Health Competence Centre Hosts Online Discussions
Pharmaguy interviews Juan Cornet, Director, mHealth Competence Center, who summarizes the key takeaways from an hour-long #mHealthPharma TweetChat on how pharma can develop high quality mobile health apps. Juan also talks more generally about the impact of mobile technology on healthcare and what his organization is doing to promote quality mHealth programs.
Questions/Topics of Discussion
Tell us about the mHealth Competence Center and its mission.
What did you learn from the LinkedIn debate and #mHealthPharma TweetChat? Do you plan more such discussions?
What other activities is he mHealth Competence Center involved in now or planned for the future?
What's your view on how mHealth can improve health inequalities that exist today? What role do you see for pharmaceutical companies?
A cure is a one-time deal. It could never amount to the consistent revenue of lifelong refills for prescription drugs. And if it's natural, Big Pharma can't patent it. That's why Big Pharma actively blocks the science and research for natural cures by renting the FDA, who are their profit protectors.
It's why they spend $180 million annually on lobbyists to push through legislation on their behalf. And it's why they leverage their control over the FDA to guarantee no disease-curing anything gets to market. If even one slipped through, it would dry up their cash flow and put their entire industry at risk.
Tune in Wednesday at 7PM est for the rest of the story
If you believe pharmaceutical corporations hold the health of the general public in high regard, it's time to reconsider. The industry is filled with examples of wrongful death, extortion, fraud, corruption, obstruction of justice, embezzlement, fake journals, harassment and hit lists that would make even the most hardened Mafia godfather blush. This week on the Health and Wellness show, we take a close look into the atrocities perpetrated on the public by this massive, psychopathic industry and emphasize alternatives to being another brick in the pharmaceutical pyramid. As always, we'll feature Zoya's Pet Health Segment.
Join us Friday mornings at 10am EST, where we expose the lies and emphasize the truth about health in our modern world.
Join Host Live Chats
- Mind Right Radio (12 chatters)
- High Frequency Radio Network (11 chatters)
- The J Ril Show (11 chatters)
- Sport City Chefs (3 chatters)
- Feldman World Group (3 chatters)
- MPowered4Life Radio Show (2 chatters)
- IWS Radio (2 chatters)
- Sharry Edwards (2 chatters)
- nXphase Records (1 chatters)
- FilmReviewPodcast (1 chatters)
- FreedomizerRadio (1 chatters)
- HisWordHisWay (1 chatters)